Integra LifeSciences Schedules Conference Call for Monday, August 8 to Discuss Second Quarter 2005 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J.--(BUSINESS WIRE)--July 25, 2005--Integra LifeSciences Holdings Corporation (Nasdaq: IART) has scheduled a conference call for 9:00 AM EST on Monday, August 8 to discuss financial results for the second quarter ended June 30, 2005 and to update forward-looking financial guidance. Financial results for the second quarter 2005 will be announced via a news release issued on August 7.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward- looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 973-935-8511 or through a webcast via a link provided on Integra's website at www.Integra-LS.com. Access to a replay is available through August 22, 2005 by dialing 973-341-3080 (PIN 6175823) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neuro-trauma and neurosurgery, reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.
CONTACT:
Integra LifeSciences Holdings Corporation
Maria Platsis,
609-936-2333
mplatsis@integra-ls.com
or
David Holtz,
609-936-2334
dholtz@integra-ls.com